BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Maggiulli R, Giancani A, Fabozzi G, Dovere L, Tacconi L, Amendola MG, Cimadomo D, Ubaldi FM, Rienzi L. Assessment and management of the risk of SARS-CoV-2 infection in an IVF laboratory. Reprod Biomed Online 2020;41:385-94. [PMID: 32693991 DOI: 10.1016/j.rbmo.2020.06.017] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Scarica C, Parmegiani L, Rienzi L, Anastasi A, Cimadomo D, Klinger FG, Licata E, Sosa Fernandez L, De Santis L. SARS-CoV-2 persistence at subzero temperatures. J Assist Reprod Genet 2021;38:779-81. [PMID: 33544317 DOI: 10.1007/s10815-021-02094-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
2 Colaco S, Chhabria K, Singh D, Bhide A, Singh N, Singh A, Husein A, Mishra A, Sharma R, Ashary N, Modi D. Expression map of entry receptors and infectivity factors for pan-coronaviruses in preimplantation and implantation stage human embryos. J Assist Reprod Genet 2021;38:1709-20. [PMID: 33913101 DOI: 10.1007/s10815-021-02192-3] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
3 Anifandis G, Messini CI, Simopoulou M, Sveronis G, Garas A, Daponte A, Messinis IE. SARS-CoV-2 vs. human gametes, embryos and cryopreservation. Syst Biol Reprod Med 2021;67:260-9. [PMID: 34060390 DOI: 10.1080/19396368.2021.1922537] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
4 Jirge PR, Patwardhan S, Jirge SN, Bhomkar DA, Chougule SM, Salpekar A, Modi D. Resuming Assisted Reproduction Services during COVID-19 Pandemic: An Initial Indian Experience. J Hum Reprod Sci 2020;13:323-32. [PMID: 33627983 DOI: 10.4103/jhrs.JHRS_211_20] [Cited by in Crossref: 4] [Article Influence: 2.0] [Reference Citation Analysis]
5 Rajput SK, Khan SA, Goheen BB, Engelhorn HJ, Logsdon DM, Grimm CK, Kile RA, West RC, Yuan Y, Schoolcraft WB, McCormick S, Krisher RL, Swain JE. Absence of SARS-CoV-2 (COVID-19 virus) within the IVF laboratory using strict patient screening and safety criteria. Reprod Biomed Online 2021;42:1067-74. [PMID: 33814309 DOI: 10.1016/j.rbmo.2021.03.005] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
6 [DOI: 10.1101/2021.01.21.427501] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
7 Wu Y, Zhang X, Wang Z, Xia X. Can We Cryopreserve the Sperm of COVID-19 Patients During the Pandemic? Front Endocrinol (Lausanne) 2022;13:753267. [PMID: 35712235 DOI: 10.3389/fendo.2022.753267] [Reference Citation Analysis]
8 Dong Y, Wu S, Shi X, Li Y, Chiclana F. Clustering method with axiomatization to support failure mode and effect analysis. IISE Transactions. [DOI: 10.1080/24725854.2022.2068812] [Reference Citation Analysis]
9 Armitage LC, Lawson BK, Thompson B, Biggs C, Rutter H, Lewis-jones M, Ede J, Tarassenko L, Farmer A, Watkinson P. Ambulatory blood pressure monitoring using telemedicine: proof-of-concept cohort and failure modes and effects analyses. Wellcome Open Res 2022;7:39. [DOI: 10.12688/wellcomeopenres.17537.1] [Reference Citation Analysis]
10 Jin P, Park H, Jung S, Kim J. Challenges in Urology during the COVID-19 Pandemic. Urol Int 2021;105:3-16. [PMID: 33227808 DOI: 10.1159/000512880] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
11 Sparks AET, Kresowik JD. Infection precautions for severe acute respiratory syndrome coronavirus 2 in assisted reproduction centers: dodging an invisible bullet. Fertil Steril 2021;115:831-9. [PMID: 33750621 DOI: 10.1016/j.fertnstert.2021.01.016] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
12 Ambarwati R, Yuliastri D, Sulistiyowati W. Human resource risk control through COVID-19 risk assessment in Indonesian manufacturing. J Loss Prev Process Ind 2022;74:104665. [PMID: 34720455 DOI: 10.1016/j.jlp.2021.104665] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Ma L, Ma X, Xing P, Yu F. A hybrid approach based on the HFACS-FBN for identifying and analysing human factors for fire and explosion accidents in the laboratory. Journal of Loss Prevention in the Process Industries 2022;75:104675. [DOI: 10.1016/j.jlp.2021.104675] [Reference Citation Analysis]
14 Anifandis G, Taylor TH, Messini CI, Chatzimeletiou K, Daponte A, Ioannou D, Tempest HG. The Impact of SARS-CoV-2 on Sperm Cryostorage, Theoretical or Real Risk? Medicina (Kaunas) 2021;57:946. [PMID: 34577870 DOI: 10.3390/medicina57090946] [Reference Citation Analysis]
15 Helmy Abdelmalek Fahmy E, Yeap BT, Pg Baharuddin DM, M A Abdelhafez M, Than WW, Soe MZ, Hayati F, Chin YS. Obstetric challenges during COVID-19 pandemic: A narrative review. Ann Med Surg (Lond) 2021;71:102995. [PMID: 34745605 DOI: 10.1016/j.amsu.2021.102995] [Reference Citation Analysis]
16 Plescia F, Cirrincione L, Martorana D, Ledda C, Rapisarda V, Castelli V, Martines F, Vinnikov D, Cannizzaro E. Alcohol Abuse and Insomnia Disorder: Focus on a Group of Night and Day Workers. Int J Environ Res Public Health 2021;18:13196. [PMID: 34948807 DOI: 10.3390/ijerph182413196] [Reference Citation Analysis]
17 Armitage LC, Lawson BK, Roman C, Thompson B, Biggs C, Rutter H, Lewis-jones M, Ede J, Tarassenko L, Farmer A, Watkinson P. Ambulatory blood pressure monitoring using telemedicine: proof-of-concept cohort and failure modes and effects analyses. Wellcome Open Res 2022;7:39. [DOI: 10.12688/wellcomeopenres.17537.2] [Reference Citation Analysis]
18 Ma L, Ma X, Zhang J, Yang Q, Wei K. A Methodology for Dynamic Assessment of Laboratory Safety by SEM-SD. Int J Environ Res Public Health 2021;18:6545. [PMID: 34204588 DOI: 10.3390/ijerph18126545] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]